{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:53:08Z","timestamp":1781704388003,"version":"3.54.5"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"crossref","award":["1800725N"],"award-info":[{"award-number":["1800725N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:p>\n                    Proliferative fasciitis (PFA) and proliferative myositis (PM) are related benign neoplasms that show large ganglion-like neoplastic cells and harbor recurrent\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    fusions. Proliferative funiculitis (PFU) is a benign mesenchymal lesion of the spermatic cord, with small ganglion-like cells and unknown etiology. Ischemic fasciitis (IFA) is a possibly reactive lesion that shows cytomorphologic overlap with PFA\/PM. Here, we assessed FOS and FOSB immunohistochemistry (IHC) in PFA (adult and pediatric), PM, PFU, and IFA. Diffuse nuclear FOS expression was detected in adult PFA (15\/26 cases; 58%) and PM (6\/10; 60%), while FOSB was consistently negative (19 adult PFA, 5 PM).\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    FISH demonstrated rearrangement in only 4 of 12 tested adult PFA\/PM, all of which were FOS-positive by IHC. A\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    fusion (\n                    <jats:italic toggle=\"yes\">FOS::TSHZ2<\/jats:italic>\n                    ) was detected in only 1 of 9 adult PFA\/PM (11%) tested by RNA sequencing (RNAseq); 5 tumors without detected\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    fusions by RNAseq were FOS-positive by IHC. The pediatric PFA lacked expression of FOS (all 9 tumors) and FOSB (4 tested tumors) by IHC. Compared with FOS-positive PFA\/PM, pediatric PFA and adult FOS-negative PFA\/PM were more frequently cellular, and pediatric tumors were less infiltrative. DNA sequencing demonstrated\n                    <jats:italic toggle=\"yes\">FOSL1<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">RELA<\/jats:italic>\n                    fusions in 2 of 5 tested pediatric PFAs, both in infants. Six of 18 PFU (33%) expressed FOS and\/or FOSB by IHC. FISH demonstrated\n                    <jats:italic toggle=\"yes\">FOSB<\/jats:italic>\n                    rearrangement in 1 of 6 PFU, while all 6 tested PFU were negative for\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    rearrangement. Nine of 20 IFA (45%) expressed FOS and\/or FOSB; 2 tested tumors were negative for\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">FOSB<\/jats:italic>\n                    fusions by RNAseq. We conclude that about 60% of adult PFA\/PM strongly express FOS, and 5 of these tumors were proven to harbor\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    rearrangements, including a novel\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    ::\n                    <jats:italic toggle=\"yes\">TSHZ2<\/jats:italic>\n                    fusion. Some PFU and pediatric PFA harbored alterations in related genes\n                    <jats:italic toggle=\"yes\">FOSB<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">FOSL1<\/jats:italic>\n                    , respectively. RNAseq and FISH might have imperfect sensitivity for\n                    <jats:italic toggle=\"yes\">FOS<\/jats:italic>\n                    alterations in PFA\/PM, likely due to the low relative neoplastic cell content in these tumor types.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002540","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:01:54Z","timestamp":1774501314000},"page":"726-738","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["FOS and FOSB Immunohistochemistry and Molecular Testing Reveal Novel Patterns in Proliferative Fasciitis and Myositis, FOSB Rearrangement in Proliferative Funiculitis, and FOSL1::RELA Fusion in Pediatric Proliferative Fasciitis"],"prefix":"10.1097","volume":"50","author":[{"given":"Sanhong","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cordier","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"CRIG, Cancer Research Institute Ghent"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Baranov","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Odintsov","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Magnusson","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Lund University, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joni","family":"Van der Meulen","sequence":"additional","affiliation":[{"name":"CRIG, Cancer Research Institute Ghent"},{"name":"Molecular Diagnostics Ghent University Hospital (MDG) and Department of Biomolecular Medicine, Ghent University Hospital, Ghent University, Ghent"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siebe","family":"Loontiens","sequence":"additional","affiliation":[{"name":"CRIG, Cancer Research Institute Ghent"},{"name":"Molecular Diagnostics Ghent University Hospital (MDG) and Department of Biomolecular Medicine, Ghent University Hospital, Ghent University, Ghent"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Ferdinande","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"CRIG, Cancer Research Institute Ghent"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Van Dorpe","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"CRIG, Cancer Research Institute Ghent"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Haglund de Flon","sequence":"additional","affiliation":[{"name":"Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Lund University, Lund"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.M.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Creytens","sequence":"additional","affiliation":[{"name":"Department of Pathology"},{"name":"CRIG, Cancer Research Institute Ghent"},{"name":"Research Foundation Flanders (FWO), Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-3546","authenticated-orcid":false,"given":"David J.","family":"Papke","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"R1-20260617","first-page":"209","article-title":"Proliferative myositis; a pseudosarcomatous reaction to injury: a report of seven cases","volume":"69","author":"Kern","year":"1960","journal-title":"Arch Pathol"},{"key":"R2-20260617","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/1097-0142(196712)20:12<2213::AID-CNCR2820201223>3.0.CO;2-L","article-title":"Proliferative myositis. Report of thirty-three cases","volume":"20","author":"Enzinger","year":"1967","journal-title":"Cancer"},{"key":"R3-20260617","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/1097-0142(197510)36:4<1450::AID-CNCR2820360437>3.0.CO;2-4","article-title":"Proliferative fasciitis","volume":"36","author":"Chung","year":"1975","journal-title":"Cancer"},{"key":"R4-20260617","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000478-199204000-00005","article-title":"Proliferative fasciitis and myositis of childhood","volume":"16","author":"Meis","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R5-20260617","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00000478-199205000-00003","article-title":"Pseudosarcomatous myofibroblastic proliferations of the spermatic cord (\u201cproliferative funiculitis\u201d). Histologic and immunohistochemical analysis of a distinctive entity","volume":"16","author":"Hollowood","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R6-20260617","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.path.2024.08.008","article-title":"Mesenchymal neoplasms of the bladder and male genital tract, including the perineum and scrotum","volume":"18","author":"Papke","year":"2025","journal-title":"Surg Pathol Clin"},{"key":"R7-20260617","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00000478-199207000-00009","article-title":"Atypical decubital fibroplasia. A distinctive fibroblastic pseudotumor occurring in debilitated patients","volume":"16","author":"Montgomery","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R8-20260617","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1097\/PAS.0b013e31816be8db","article-title":"Ischemic fasciitis: analysis of 44 cases indicating an inconsistent association with immobility or debilitation","volume":"32","author":"Liegl","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R9-20260617","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41379-020-00725-2","article-title":"Recurrent FOS rearrangement in proliferative fasciitis\/proliferative myositis","volume":"34","author":"Makise","year":"2021","journal-title":"Mod Pathol"},{"key":"R10-20260617","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/his.14716","article-title":"Preliminary exploration of the role of FOS immunohistochemistry in proliferative fasciitis and myositis","volume":"81","author":"Vargas","year":"2022","journal-title":"Histopathology"},{"key":"R11-20260617","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jcp-2023-208931","article-title":"New kids on the block: FOS and FOSB gene","volume":"76","author":"Cordier","year":"2023","journal-title":"J Clin Pathol"},{"key":"R12-20260617","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/path.4683","article-title":"FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma","volume":"238","author":"Puls","year":"2016","journal-title":"J Pathol"},{"key":"R13-20260617","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/PAS.0000000000001974","article-title":"Epithelioid and spindle cell hemangioma: clinicopathologic analysis of 18 primary bone and soft tissue tumors highlighting a predilection for the hands and feet, frequent multicentricity, and benign behavior","volume":"47","author":"Papke","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R14-20260617","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"R15-20260617","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of oncopanel a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"R16-20260617","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/10668969221101867","article-title":"Immunohistochemistry for FOSB and FOS is a useful ancillary tool in the diagnosis of epithelioid hemangioma but there are pitfalls in interpretation including expression in other vascular lesions","volume":"31","author":"Tsui","year":"2023","journal-title":"Int J Surg Pathol"},{"key":"R17-20260617","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/PAS.0000000000000795","article-title":"FOSB is a useful diagnostic marker for pseudomyogenic hemangioendothelioma","volume":"41","author":"Hung","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R18-20260617","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/bjh.12586","article-title":"Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome","volume":"164","author":"Brezinova","year":"2014","journal-title":"Br J Haematol"},{"key":"R19-20260617","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/labinvest.2012.46","article-title":"FOSL1 as a candidate target gene for 11q12 rearrangements in desmoplastic fibroblastoma","volume":"92","author":"Macchia","year":"2012","journal-title":"Lab Invest"},{"key":"R20-20260617","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/his.13042","article-title":"FOSL1 immunohistochemistry clarifies the distinction between desmoplastic fibroblastoma and fibroma of tendon sheath","volume":"69","author":"Kato","year":"2016","journal-title":"Histopathology"},{"key":"R21-20260617","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/path.6038","article-title":"Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma","volume":"259","author":"De Noon","year":"2023","journal-title":"J Pathol"},{"key":"R22-20260617","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/his.15462","article-title":"Hyalinised fibrocartilaginous tumour of bone: probable new histological entity with FOSL1 gene rearrangement","volume":"87","author":"Amary","year":"2025","journal-title":"Histopathology"},{"key":"R23-20260617","doi-asserted-by":"crossref","first-page":"100283","DOI":"10.1016\/j.labinv.2023.100283","article-title":"Osteosarcomas with few chromosomal alterations or adult onset are genetically heterogeneous","volume":"104","author":"Difilippo","year":"2024","journal-title":"Lab Invest"},{"key":"R24-20260617","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1177\/10668969231188893","article-title":"Lack of FOS\/FOSB gene rearrangements in ischemic fasciitis indicates distinct pathogenesis from proliferative fasciitis and proliferative myositis","volume":"32","author":"Zilla","year":"2024","journal-title":"Int J Surg Pathol"},{"key":"R25-20260617","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1066896907307235","article-title":"Mesothelial glandular structures within pseudosarcomatous proliferative funiculitis\u2014a diagnostic pitfall: report of 17 cases","volume":"16","author":"Michal","year":"2008","journal-title":"Int J Surg Pathol"},{"key":"R26-20260617","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1066896918820443","article-title":"Proliferative funiculitis-like dedifferentiated liposarcoma with mesothelial glandular structures: a diagnostic pitfall","volume":"27","author":"Konstantinov","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"R27-20260617","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1242\/jcs.01589","article-title":"AP-1 subunits: quarrel and harmony among siblings","volume":"117","author":"Hess","year":"2004","journal-title":"J Cell Sci"},{"key":"R28-20260617","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.ejca.2005.08.008","article-title":"The Fos family of transcription factors and their role in tumourigenesis","volume":"41","author":"Milde-Langosch","year":"2005","journal-title":"Eur J Cancer"},{"key":"R29-20260617","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/PAS.0000000000000469","article-title":"Frequent FOS gene rearrangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal","volume":"39","author":"Huang","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R30-20260617","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/gcc.22269","article-title":"Fusion events lead to truncation of FOS in epithelioid hemangioma of bone","volume":"54","author":"van IJzendoorn","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"R31-20260617","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/s41467-018-04530-z","article-title":"Recurrent rearrangements of FOS and FOSB define osteoblastoma","volume":"9","author":"Fittall","year":"2018","journal-title":"Nat Commun"},{"key":"R32-20260617","doi-asserted-by":"crossref","first-page":"21282","DOI":"10.1074\/jbc.C117.815845","article-title":"Functional analyses of a human vascular tumor FOS variant identify a novel degradation mechanism and a link to tumorigenesis","volume":"292","author":"Van IJzendoorn","year":"2017","journal-title":"J Biol Chem"},{"key":"R33-20260617","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/path.70010","article-title":"Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NF\u03baB signalling in an in vitro cell-of-origin model for osteoid osteoma and osteoblastoma","volume":"268","author":"Lam","year":"2025","journal-title":"J Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:03:44Z","timestamp":1781701424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002540","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}